Escalon Medical Corp (ESMC) NPV

Sell:$0.16Buy:$0.16No change

Prices delayed by at least 15 minutes
Sell:$0.16
Buy:$0.16
Change:No change
Prices delayed by at least 15 minutes
Sell:$0.16
Buy:$0.16
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Escalon Medical Corp. operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices for ophthalmic applications. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration. Its products include A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, and AXIS Image Management. A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. B-Scan is primarily a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. UBM is a high frequency/high resolution ultrasound device. AXIS Image Management system manages ophthalmic diagnostic images via a Web browser from any device regardless of modality, device manufacturer or location.

Key people

Richard J. DePiano
Chairman of the Board
Richard J DePiano
President, Chief Executive Officer, General Counsel, Director
Mark G. Wallace
Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer
John P. Dogum
Director
David J. Jacovini
Director
C. Todd Trusk
Director
Fred G. Choate
Independent Director
Lisa A. Napolitano
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US2960743050
  • Market cap
    $1.15m
  • Employees
    40
  • Shares in issue
    7.42m
  • Exchange
    Over The Counter
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.